FDAapproval84% confidence
Competitive Generic Therapy Approvals
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Strides Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Explore the FDA’s Competitive Generic Therapy Approvals page, offering insights into the program designed to encourage generic drug competition. Access information about approved CGT products and find resources, including a downloadable CGT approvals spreadsheet.
Supporting Context
- Therapeutic area
- Immunology · Immunosuppressant
- Sub-indication
- General
Related signal: FDA Approval Process Update for Mycophenolate Mofetil by Strides Pharma